Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BARI-OPTIMISE: Liraglutide post-bariatric surgery
NCT03341429Phase 4Completed
- Sponsor
- University College London
- Start
- Aug 2018
- Primary completion
- Nov 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in obesity, sponsored by University College London. Started Aug 2018; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT03341429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03341429.